Notification and public disclosure of transactions by persons discharging managerial responsibilities
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||||
a) |
Name |
Mary Regina (Nina) Henderson |
||||||
2 |
Reason for the notification |
|||||||
a) |
Position/status |
Non-executive Director |
||||||
b) |
Initial notification /Amendment |
Initial notification |
||||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||
a) |
Name |
Hikma Pharmaceuticals PLC |
||||||
b) |
LEI |
549300BNS685UXH4JI75 |
||||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||
a) |
Description of the financial instrument, type of instrument and identification code |
Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
||||||
b) |
Nature of the transaction
|
Market purchase of 1,600 Shares by Mary R Henderson Revocable Trust. |
||||||
c) |
Price(s) and volume(s) |
Price(s): £22.03 Volume(s): 1,600 |
||||||
d) |
Aggregated information - Volume - Price - Total |
£35,248.00 |
||||||
e) |
Date of the transaction |
17 March 2021 |
||||||
f) |
Place of the transaction |
London Stock Exchange (XLON) |
Peter Speirs
Company Secretary, responsible for releasing this announcement
+44 (0) 20 7399 2760
17 March 2021